menu search

AMED / Amedisys, Inc.: Why Stock Is A Hold Pending Agency Review

Amedisys, Inc.: Why Stock Is A Hold Pending Agency Review
Amedisys, Inc. is set to be acquired by UnitedHealth Group in a $3.29 billion merger agreement. Some US legislators have called for further scrutiny of the merger, citing concerns of increased market dominance and higher medical costs. UnitedHealth's subsidiary, Optum Group, has been expanding its service provision through acquisitions, including a recent deal with UK health-tech company EMIS Group. Read More
Posted: Nov 3 2023, 10:08
Author Name: Seeking Alpha
Views: 030178

AMED News  

Amedisys, Inc.: Why Stock Is A Hold Pending Agency Review

By Seeking Alpha
November 3, 2023

Amedisys, Inc.: Why Stock Is A Hold Pending Agency Review

Amedisys, Inc. is set to be acquired by UnitedHealth Group in a $3.29 billion merger agreement. Some US legislators have called for further scrutiny o more_horizontal

Amedisys (AMED) Reports Q3 Earnings: What Key Metrics Have to Say

By Zacks Investment Research
October 24, 2023

Amedisys (AMED) Reports Q3 Earnings: What Key Metrics Have to Say

Although the revenue and EPS for Amedisys (AMED) give a sense of how its business performed in the quarter ended September 2023, it might be worth con more_horizontal

Amedisys (AMED) Q3 Earnings and Revenues Lag Estimates

By Zacks Investment Research
October 24, 2023

Amedisys (AMED) Q3 Earnings and Revenues Lag Estimates

Amedisys (AMED) came out with quarterly earnings of $0.98 per share, missing the Zacks Consensus Estimate of $1.08 per share. This compares to earning more_horizontal

Is Amedisys (AMED) Stock Outpacing Its Medical Peers This Year?

By Zacks Investment Research
October 18, 2023

Is Amedisys (AMED) Stock Outpacing Its Medical Peers This Year?

Here is how Amedisys (AMED) and Cybin Inc. (CYBN) have performed compared to their sector so far this year. more_horizontal

Amedisys (AMED) Q2 Earnings Beat Estimates, Margins Dip

By Zacks Investment Research
July 28, 2023

Amedisys (AMED) Q2 Earnings Beat Estimates, Margins Dip

Strength in Hugh Acuity Care segment and Hospice division drive Amedisys (AMED) Q2 performance. more_horizontal

Amedisys (AMED) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

By Zacks Investment Research
July 26, 2023

Amedisys (AMED) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

While the top- and bottom-line numbers for Amedisys (AMED) give a sense of how the business performed in the quarter ended June 2023, it could be wort more_horizontal

UnitedHealth's Amedisys Deal Come as Home Health and Data Cement Care Ecosystems

By PYMNTS
June 26, 2023

UnitedHealth's Amedisys Deal Come as Home Health and Data Cement Care Ecosystems

In healthcare, the latest acquisition brings to mind that old Fred Astaire song lyric: “Won't you change partners and dance with me?” On Monday,  more_horizontal

UnitedHealth Buys Amedisys for $3.3 Billion

By Investopedia
June 26, 2023

UnitedHealth Buys Amedisys for $3.3 Billion

UnitedHealth Group outbid Option Care's offer to buy home healthcare provider Amedisys. more_horizontal


Search within

Pages Search Results: